CELL THERAPY FROM THE BENCH TO THE BEDSIDE AND RETURN

Fechas y lugar de celebración

Plazos

Objetivos

The aim of this course is the diffusion of knowledge about stem cells and their therapeutic possibilities, with a special emphasis on Adult Stem Cells such as Hematopoietic Stem Cells and Mesenchymal Stems, and their current applications in the field of Regenerative Medicine.

The course is intended to provide a forum for scientific discussion with basic researchers and clinical experts in cellular therapy, and to set out the achievements and challenges in this exciting and growing area of clinical medicine therapy.

Specific Course Objectives are:

To analyze in depth the different types of stem cells, their biological properties, their laboratory manipulation and their clinical use.

To learn about the new types of hematopoietic cell transplantation, and new approaches of immune modulation.

To discuss the present status of preclinical studies and clinical trials of stem cell therapy for repair of damaged tissues and organs.

Organización de la actividad

Dirección

Coordinadores:

Requisitos de acceso

Students, graduates and others interested in the subject.

Datos generales

Precios

Programa

Lunes 15 Bone Marrow Stem Cells: Hematopoietic Stem Cells (HSC) and Hematopoietic Stem Cell Transplantation (HSCT)

  • 09:00 h. Conferencia inaugural: Open Session
    • Excma. Sra. Dña. María Ángeles Palacios Sánchez
      Health Conuncil of the Autonomous Community of the Region of Murcia. Murcia. Spain.
    • Excmo. Sr. Rector Magnífico de la Universidad de Murcia José Antonio Cobacho Gómez
      Rector of the University of Murcia. Murcia. Spain.
    • Ilmo. Sr. D. Antonio L. Andreu Périz
      Director General, Institute of Health Carlos III. Spain. Madrid.
    • Prof. Dr. D. José María Moraleda Jiménez
      Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
  • 09:30 h. Ponencia: The Biology of the Hematopoietic Stem Cell
    • Dra. Dña. Carmen Luisa Garcia de Insausti
      Asociado Ciencias de la Salud. Murcia.
  • 10:00 h. Ponencias: Obtaining Hematopoietic Progenitors: Cellular Selection
    • Dr. D. Miguel Blanquer Blanquer
      Hematólogo HCUVA. Murcia.
  • 10:30 h. Pausa. Coffee break
  • 11:00 h. Ponencia: HSCT: Technique and Complications
    • Prof. Dr. D. José María Moraleda Jiménez
      Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
  • 11:30 h. Ponencia: Umbilical Cord Blood Transplantation
    • Dr. D. Vanderson Rocha
      Scientific Director Of Eurocord Registry. Departmen Of Hematology BMT, Hospital Saint Louis. University of Paris. France.
  • 12:15 h. Ponencia: Principles and Practice of Non-myeloablative HSCT
    • Prof. Dr. D. Sergio A. Giralt
      Professor of Medicine Weill Cornell College of Medicine. Chief, Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
  • 13:00 h. Pausa. Lunch
  • 15:00 h. Ponencia: Short Lecture: Curing Hemoglobinopathies
    • Prof. Dr. D. Franco Locatelli
      President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
  • 15:30 h. DEBATE: Debate session: Histocompatibility Antigen (HLA) Typing, HSC Donation, and Registry Issues.
    • The Spanish Model
      Gregorio Garrido Cantarero. Head of Service, Spanish National Transplant Organization (ONT). Madrid, Spain.
    • The French Registry
      Dr. D. Vanderson Rocha. Scientific Director Of Eurocord Registry. Departmen Of Hematology BMT, Hospital Saint Louis. University of Paris. France.
    • The Great Britain Experience
      Prof. Dr. D. José Alejandro Madrigal Fernández. European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
    • Prof. Dr. D. José María Moraleda Jiménez
      Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.

Martes 16 New HSCT Approches: HSCT Immunotherapy

  • 09:00 h. Ponencia: The Immunotherapeutic Role of HSCT
    • Prof. Dr. D. Andrea Bacigalupo
      Head Department of Hematology and Stem Cell Transplant Unit. Ospedale San Martino. Genova. Italy.
  • 09:45 h. Ponencia: Haploidentical Transplants and Role of NK Immunotherapy
    • Prof. Dr. D. Franco Locatelli
      President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
  • 10:30 h. Pausa. Coffee break
  • 11:00 h. Ponencia: New Strategies for Post-transplant Immunomodulation
    • Prof. Dr. D. José Alejandro Madrigal Fernández
      European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
  • 11:45 h. Ponencia: Unrelated Donor Transplants. The MSK Experience in HSCT Immunomodulation
    • Prof. Dr. D. Sergio A. Giralt
      Professor of Medicine Weill Cornell College of Medicine. Chief, Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
  • 12:30 h. Pausa. Lunch
  • 14:30 h. DEBATE: Debate session: Harnessing GVL Effect while Avoiding GVHD. What is the best URD transplant?
    • URD unmanipulated SCT
      Prof. Dr. D. José Alejandro Madrigal Fernández. European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
    • T-selected Haploidentical transplant
      Prof. Dr. D. Franco Locatelli. President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
    • Double cord transplant
      Prof. Dr. D. Sergio A. Giralt. Professor of Medicine Weill Cornell College of Medicine. Chief, Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
    • Single UC transplant
      Dr. D. Vanderson Rocha. Scientific Director Of Eurocord Registry. Departmen Of Hematology BMT, Hospital Saint Louis. University of Paris. France.
    • Lymphocyte infusions
      Prof. Dr. D. Andrea Bacigalupo. Head Department of Hematology and Stem Cell Transplant Unit. Ospedale San Martino. Genova. Italy.
    • Prof. Dr. D. Robert Sackstein
      Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.

Miércoles 17 MORNING: Bone Marrow Stem Cells: Mesenchymal Stem Cells (MSC) and Mesenchymal Stem Cell Transplantation. AFTERNOON: Induced Pluripotent Stem Cells (iPSC)

  • 09:00 h. Ponencia: The stem Cell Niche
    • Prof. Dr. D. Agustín Gregorio Zapata González
      Professor of Cellular Biology. Complutense University of Madrid. Spain.
  • 09:30 h. Ponencia: The Regulation of the Stem Cell Microenvironment
    • Dr. D. Simón Méndez Ferrer
      National Center for Cardiovascular Research (CNIC). Madrid, Spain.
  • 10:00 h. Ponencia: MSC: A New Paradigm for Cell Immunomodulation
    • Prof. Dr. D. Antonio Uccelli
      Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
  • 10:45 h. Pausa. Coffee break
  • 11:15 h. Ponencia: Stem Cell Trafficking: Biology and Manipulation via GPS
    • Prof. Dr. D. Robert Sackstein
      Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
    • Dra. Dña. Mª Dolores López Lucas
      Unidad de Trasplante y Terapia Celular. Hospital Clínico Universitario Virgen de la Arrixaca. University of Murcia. Spain.
    • Prof. Dr. D. José María Moraleda Jiménez
      Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
  • 12:30 h. Ponencia: The production os MSC for clinical use: GMP cell facilities
    • Prof. Dra. Dña. Ana Sánchez García
      Professor of Physiology. School of Medicine. Institute of Biology and Molecular Genetics (IBGM). University of Valladolid, Spain.
  • 13:00 h. Pausa. Lunch
  • 15:00 h. Ponencia: iPSC as a Therapeutic Tool
    • Prof. Dr. D. Ángel Raya Chamorro
      ICREA Research Professor. Institute for Bioengineering of Catalonia. Barcelona, Spain.
  • 15:30 h. Ponencia: iPSC and Gene Therapy for Genetic Diseases
    • Prof. Dr. D. Juan Antonio Bueren Roncero
      Head of the Division of Hematopoiesis and Gene Therapy Division CIEMAT. University of Madrid. Spain.

Jueves 18 Stem Cell Therapy (SCT). Clinical Trials in Non-neurologic Diseases

  • 09:00 h. Ponencia: SCT in Cardiac Diseases
    • Prof. Dr. D. Felipe Prosper Cardoso
      Director of Cell Therapy Department. Co-director Hematology Dpt. University of Navarra. Navarra, Spain.
  • 09:30 h. Ponencia: SCT in Diabetes Mellitus and its Complications
    • Prof. Dr. D. Bernat Soria Escoms
      Director of the Stem Cells Department of the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER). University Pablo de Olavide. Seville, Spain.
  • 10:00 h. Ponencia: SCT to Improve Surgical Healing
    • Prof. Dr. D. Damián García Olmo
      Jefe Cirugía. Madrid.
  • 10:30 h. Pausa. Coffee break
  • 11:00 h. Ponencia: SCT for Bone Repair
    • Prof. Dr. D. Francisco Javier García-Sancho Martín
      Professor of Physiology. School of Medicine. Institute of Biology and Molecular Genetics (IBGM). University of Valladolid. Spain.
  • 11:30 h. Ponencia: SCT for Cartilage Repair
    • Prof. Dr. D. Pedro Guillén García
      Clinical Research Unit, CEMTRO Hospital. Madrid, Spain.
  • 12:00 h. Ponencia: SCT for Treatment of Transplant Rejection and GVHD
    • Dr. D. Fermín M. Sánchez Guijo
      Hematology Department. University Hospital of Salamanca. University of Salamanca. Spain.
  • 13:00 h. Pausa. Lunch
  • 15:00 h. Ponencia: SCT in Ophthalmology
    • Prof. Dra. Dña. Margarita Calonge
      Professor of Ophthalmology. Director, Ocular Immunology Unit, IOBA, University of Valladolid. Spain.
  • 15:30 h. Ponencia: SCT in Odontology
    • Prof. Dr. D. Francisco Javier Rodríguez Lozano
      Professor of Dentistry. Cell Therapy Research Group. Virgen de la Arrixaca University Hospital. University of Murcia. Spain.

Viernes 19 Stem Cell Therapy (SCT). Clinical Trials in Neurologic Diseases

  • 09:00 h. Ponencia: The Neural Stem Cell niche
    • Prof. Dra. Dña. Isabel Fariñas Gómez
      Professor of Cellular Biology. Dept. of Cellular Biology. University of Valencia CIPF. Valencia, Spain.
  • 09:30 h. Ponencia: SCT in Parkinson's Disease
    • Prof. Dr. D. Juan José Toledo Aral
      Professor of Physiology. Department of Medical Physiology and Biophysics. University of Seville. Seville, Spain.
  • 10:00 h. Ponencia: SCT in ALS
    • Dra. Dña. Letizia Mazzini
      Head of the tertiary ALS Center. Department of Neurology, Eastern Piedmont. University, Maggiore della Carità Hospital. Novara, Italy.
  • 10:30 h. Pausa. Coffee break
  • 11:00 h. Ponencia: SCT in Neurodegenerative Diseases (ND). Results in Animal Models
    • Prof. Dr. D. Salvador Martínez Pérez
      Professor of Neuro-Anatomy and Embryology. Experimental Embryology Lab. Institute of Neurosciences-CSIC, Universidad Miguel Hernández. Alicante, Spain.
  • 11:30 h. Ponencia: SCT for other ND-Neuromuscular diseases
    • Prof. Dr. D. Antonio Uccelli
      Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
  • 12:00 h. Ponencia: Stem cell differentiation for cell replacement strategies in ND
    • Prof. Dr. D. Josep M. Canals Coll
      Professor of Cellular Biology. Dept. of Cell Biology, Immunology and Neuroscience. University of Barcelona. Barcelona, Spain.
  • 13:00 h. Pausa. Lunch
  • 15:00 h. DEBATE: Debate session: Stem Cell Therapy pros and cons. How do we move ahead?
    • Lecture 1
      Prof. Dr. D. Salvador Martínez Pérez. Professor of Neuro-Anatomy and Embryology. Experimental Embryology Lab. Institute of Neurosciences-CSIC, Universidad Miguel Hernández. Alicante, Spain.
    • Lecture 2
      Prof. Dr. D. Antonio Uccelli. Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
    • Lecture 3
      Prof. Dr. D. Felipe Prosper Cardoso. Director of Cell Therapy Department. Co-director Hematology Dpt. University of Navarra. Navarra, Spain.
    • Lecture 4
      Dra. Dña. Letizia Mazzini. Head of the tertiary ALS Center. Department of Neurology, Eastern Piedmont. University, Maggiore della Carità Hospital. Novara, Italy.
    • Lecture 5
      Prof. Dr. D. Robert Sackstein. Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
    • Prof. Dr. D. Agustín Gregorio Zapata González
      Professor of Cellular Biology. Complutense University of Madrid. Spain.
  • Clausura y entrega de diplomas

Aclaraciones

Solicitado reconocimiento de interés científico-sanitario.

En el precio de la matrícula está incluída la comida del medio día.